drugset / Trial / NCT01098318
Rhodiola Rosea Therapy of Major Depressive Disorder
Phase 3
Completed
58 enrolled
University of Pennsylvania
National Center for Complementary and Integrative Health (NCCIH) · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
Prior research has shown that Rhodiola rosea may be an effective, short-term, anti-depressant therapy. This study will examine the anti-depressant effect of Rhodiola rosea vs. a conventional, anti-depressant drug in the treatment of major depression.
Timeline
- Start
- 2010-06
- Primary completion
- 2013-07
- Completion
- 2013-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rhodiola | Traditional medicine (herbal / TCM) | 340 mg | — |
| Subject | Rhodiola | Traditional medicine (herbal / TCM) | 1360 mg | — |
| Comparator | Sertraline | Small molecule | 50 mg | — |
| Comparator | Sertraline | Small molecule | 200 mg | — |